Jeong Hyun Ju, Park Hyeji, Yuen Steffi Kar Kei, Castillo Christine Joy, Oh Seung-June, Cho Sung Yong
Department of Medical Device Development, Seoul National University College of Medicine, Seoul, Korea.
Department of Urology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.
Ther Adv Urol. 2024 Nov 28;16:17562872241303457. doi: 10.1177/17562872241303457. eCollection 2024 Jan-Dec.
This study evaluates surgical outcomes in benign prostatic hyperplasia (BPH) patients undergoing transurethral enucleation using various holmium laser (HoLEP) settings and/or bipolar devices (BipoLEP).
This study was retrospective.
We retrospectively analyzed 158 BPH patients treated surgically, categorized by method: BipoLEP ( = 28), HoLEP with short pulse (HoLEP-SP, = 26), HoLEP with long pulse and low energy (HoLEP-LP/LE, = 29), HoLEP with long pulse and high energy (HoLEP-LP/HE, = 26), HoLEP using Moses technology (HoLEP-Mo, = 19), and a combination of HoLEP and BipoLEP (HoLEP-mix, = 30). We assessed enucleation, morcellation, coagulation, and overall operation efficiency, along with complications at immediate, 2-week, and 3-month postoperative intervals.
The HoLEP-LP/LE group exhibited the highest overall operation efficiency ( < 0.05). The BipoLEP and HoLEP-SP groups had lower enucleation efficiency ( < 0.05). HoLEP-LP/LE and BipoLEP showed superior coagulation efficiency ( < 0.05). Excluding hard nodule cases, the HoLEP-mix group had reduced morcellation efficiency compared to HoLEP-LP/LE ( < 0.05). Complication rates did not significantly differ between groups ( > 0.05).
The HoLEP-LP/LE procedure demonstrated superior performance in enucleation, morcellation, coagulation, and overall operation efficiency. Complication rates were comparable across all groups. BipoLEP, while less efficient in enucleation than some HoLEP settings, proved effective and safe. In addition, the Moses technology may offer enhanced bleeding control.
本研究评估了接受经尿道剜除术的良性前列腺增生(BPH)患者在使用各种钬激光(HoLEP)设置和/或双极设备(BipoLEP)时的手术效果。
本研究为回顾性研究。
我们回顾性分析了158例接受手术治疗的BPH患者,按方法分类:双极等离子体前列腺剜除术(BipoLEP,n = 28)、短脉冲钬激光前列腺剜除术(HoLEP-SP,n = 26)、长脉冲低能量钬激光前列腺剜除术(HoLEP-LP/LE,n = 29)、长脉冲高能量钬激光前列腺剜除术(HoLEP-LP/HE,n = 26)、使用摩西技术的钬激光前列腺剜除术(HoLEP-Mo,n = 19),以及钬激光前列腺剜除术和双极等离子体前列腺剜除术联合使用(HoLEP-mix,n = 30)。我们评估了剜除、粉碎、凝血以及总体手术效率,以及术后即刻、2周和3个月时的并发症情况。
HoLEP-LP/LE组总体手术效率最高(P < 0.05)。BipoLEP组和HoLEP-SP组的剜除效率较低(P < 0.05)。HoLEP-LP/LE组和BipoLEP组的凝血效率更高(P < 0.05)。排除硬结节病例后,HoLEP-mix组与HoLEP-LP/LE组相比,粉碎效率降低(P < 0.05)。各组间并发症发生率无显著差异(P > 0.05)。
HoLEP-LP/LE手术在剜除、粉碎、凝血和总体手术效率方面表现出色。所有组的并发症发生率相当。BipoLEP虽然在剜除方面比某些HoLEP设置效率低,但被证明是有效且安全的。此外,摩西技术可能在控制出血方面更具优势。